Afzal Ali R, Mandal Kaushik, Nyamweya Samuel, Foteinos Georgios, Poloniecki Jan, Camm A John, Jahangiri Marjan, Xu Qingbo
Department of Clinical Developmental Sciences, St George's University of London, London, UK.
Cardiology. 2008;110(1):45-52. doi: 10.1159/000109406. Epub 2007 Oct 10.
Atrial fibrillation (AF) is a common arrhythmia encountered following cardiac surgery. Previously, we have shown that higher expression of heat shock protein (HSP) 70 was associated with decreased incidence of postoperative AF (PoAF), suggestive of an antiarrhythmic role.
We have hypothesised that Met493Thr substitution of one of the important hsp70 genes may cause loss of these protective antiarrhythmic effects. We therefore set out to examine the influence of hsp70 genotype on the incidence of PoAF.
We prospectively recruited 244 Caucasian patients undergoing elective coronary artery bypass surgery. The median age was 65 years (40-80 years). PoAF was defined as the characteristic arrhythmia lasting for at least 15 min, occurring within first week following surgery and requiring treatment. This occurred in 48 patients (19.7%). Validated Met493Thr substitution in hsp70-Hom was determined using established techniques. Of 244 patients, genotype was determined for 242 cases. The three genotypes (MM, MT, and TT) were present at frequencies of 0.66, 0.31, and 0.03, respectively, and were in Hardy-Weinberg equilibrium. In unifactorial analysis patients carrier or homozygous for 493Thr mutation had significantly higher incidence of PoAF (Pearson chi(2) = 4.3, p = 0.037). Multivariate analysis confirmed the positive association of hsp70-Hom with PoAF (OR, 2.43; p = 0.016) independent of age, sex, previous myocardial infarction, number of distal anastomoses, and duration of ventilation, respectively. Serum HSP70 was ranging from 0.74 to 31.91 ng/ml (median, 2.89) and was not correlated with PoAF. Presence of 493Thr mutation was also significantly correlated with higher levels of serum HSP70 (p = 0.009).
Our data show that a mutation in hsp70-Hom gene is associated with higher incidence of PoAF. These findings are consistent with our previous results and may suggest that patients harbouring this substitution will have less endogenous myocardial protection against AF in stressful situations.
心房颤动(AF)是心脏手术后常见的心律失常。此前,我们已经表明热休克蛋白(HSP)70的高表达与术后房颤(PoAF)发生率降低相关,提示其具有抗心律失常作用。
我们推测重要的hsp70基因之一的Met493Thr替代可能导致这些保护性抗心律失常作用丧失。因此,我们着手研究hsp70基因型对PoAF发生率的影响。
我们前瞻性招募了244例接受择期冠状动脉搭桥手术(CABG)的白种人患者。中位年龄为65岁(40 - 80岁)。PoAF定义为特征性心律失常持续至少15分钟,发生在术后第一周内且需要治疗。48例患者(19.7%)发生了PoAF。使用既定技术确定hsp70-Hom中经过验证的Met493Thr替代。244例患者中,242例确定了基因型。三种基因型(MM、MT和TT)的出现频率分别为0.66、0.31和0.03,且处于哈迪-温伯格平衡。单因素分析中携带493Thr突变的杂合子或纯合子患者PoAF发生率显著更高(Pearson卡方检验=4.3,p = 0.037)。多因素分析证实hsp70-Hom与PoAF呈正相关(比值比,2.43;p = 0.016),分别独立于年龄、性别、既往心肌梗死、远端吻合数量和通气时间。血清HSP70范围为0.74至31.91 ng/ml(中位数,2.89),与PoAF无关。493Thr突变的存在也与血清HSP70水平较高显著相关(p = 0.009)。
我们的数据表明hsp70-Hom基因突变与PoAF发生率较高相关。这些发现与我们之前的结果一致,可能表明携带这种替代的患者在应激情况下对房颤的内源性心肌保护作用较弱。